<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2024 19_11-12_602</article-id>
<article-id pub-id-type="doi">10.15836/ccar2024.602</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Invasive and interventional cardiology</subject></subj-group>
</article-categories>
<title-group>
<article-title>Nursing considerations in transcatheter aortic valve implantation: pre and post-care</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7683-2837</contrib-id><name><surname>Romi&#x0107;</surname><given-names>Marija</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<aff id="aff1"><institution>University Hospital of Split</institution>, <addr-line>Split</addr-line>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Marija Romi&#x0107;, Klini&#x010D;ki bolni&#x010D;ki centar Split, &#x0160;oltanska 2, HR-21000 Split, Croatia. / Phone: +385-97-6151-277 / E-mail: <email xlink:href="marijaromic31@gmail.com">marijaromic31@gmail.com</email></corresp></author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>11</month><year>2024</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>11</month><year>2024</year></pub-date>
<volume>19</volume>
<issue>11-12</issue>
<fpage>602</fpage>
<lpage>602</lpage>
<history>
<date date-type="received"><day>10</day><month>10</month><year>2024</year></date>
<date><day>31</day><month>10</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>Croatian Cardiac Society</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>aortic stenosis</kwd><kwd>transcatheter aortic valve replacement</kwd></kwd-group>
</article-meta>
</front>
<body>
<p>Whereas surgical aortic valve replacement (SAVR) has been the traditional treatment option for decades for patients with severe aortic stenosis (AS), more recently transcatheter aortic valve replacement (TAVR) has become a widely used alternative to surgery based on clinical trials suggesting comparable efficacy and safety profiles among patients at intermediate or high surgical risk. During the first decade of TAVR innovation, there has been development of improved devices, multimodality assessment, case selection and procedural approaches by the researchers and clinicians. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>) That resulted in TAVR rapidly becoming established as a safe and effective treatment option for people with symptomatic severe AS with surgical profiles ranging from prohibitive to low and has surpassed SAVR as the preferred treatment for AS in multiple international jurisdictions. (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>, <xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) This accelerated success has enabled us to refocus our attention from &#x201E; how we do TAVR&#x201C; task to &#x201E; how we care for TAVR patients&#x201C; task. New focus is driven by early clinical experience, and the pressing need to standardize processes of care to consistently achieve excellent outcomes, patient experiences, and program efficiencies. A successful TAVI program aims to resolve AS safely and efficiently, enabling the patient to be discharged home rapidly without sustaining in-hospital complications and thus improving outcomes. In order to achieve these goals, it is necessary to implement a standardized clinical pathway. Implementing a streamlined TAVI patient pathway requires engagement of TAVI heart team, other hospital staff (cardiac program administration, care coordinators), patients and their families. The dedicated TAVR nurses play a pivotal role in optimizing patients&#x2019; pathway, communication, and program efficiencies. The goal of TAVR care is to enable patient&#x2019;s easy transitions from their preprocedural assessment pathway and procedure planning to their periprocedural experience and finally to their postprocedural care. As such, the adoption of best practices must encompass a single clinical pathway inclusive of all time points to improve transitions of care and multidisciplinary collaboration.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauck</surname><given-names>SB</given-names></name><name><surname>Wood</surname><given-names>DA</given-names></name><name><surname>Baumbusch</surname><given-names>J</given-names></name><name><surname>Kwon</surname><given-names>JY</given-names></name><name><surname>Stub</surname><given-names>D</given-names></name><name><surname>Achtem</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of Stay.</article-title> <source>Circ Cardiovasc Qual Outcomes</source>. <year>2016</year> May;<volume>9</volume>(<issue>3</issue>):<fpage>312</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.115.002541</pub-id><pub-id pub-id-type="pmid">27116975</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolkailah</surname><given-names>AA</given-names></name><name><surname>Doukky</surname><given-names>R</given-names></name><name><surname>Pelletier</surname><given-names>MP</given-names></name><name><surname>Volgman</surname><given-names>AS</given-names></name><name><surname>Kaneko</surname><given-names>T</given-names></name><name><surname>Nabhan</surname><given-names>AF</given-names></name></person-group>. <article-title>Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk.</article-title> <source>Cochrane Database Syst Rev</source>. <year>2019</year> December 20;<volume>12</volume>(<issue>12</issue>):<elocation-id>CD013319</elocation-id>. <pub-id pub-id-type="doi">10.1002/14651858.CD013319.pub2</pub-id><pub-id pub-id-type="pmid">31860123</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundi</surname><given-names>H</given-names></name><name><surname>Strom</surname><given-names>JB</given-names></name><name><surname>Valsdottir</surname><given-names>LR</given-names></name><name><surname>Elmariah</surname><given-names>S</given-names></name><name><surname>Popma</surname><given-names>JJ</given-names></name><name><surname>Shen</surname><given-names>C</given-names></name><etal/></person-group> <article-title>Trends in Isolated Surgical Aortic Valve Replacement According to Hospital-Based Transcatheter Aortic Valve Replacement Volumes.</article-title> <source>JACC Cardiovasc Interv</source>. <year>2018</year> November 12;<volume>11</volume>(<issue>21</issue>):<fpage>2148</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcin.2018.07.002</pub-id><pub-id pub-id-type="pmid">30343022</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
